scholarly journals 28.G. Workshop: Foresight studies at the global, European and national level: what can we learn from them?

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
◽  

Abstract Foresight studies provide valuable information for (strategic) policy-making. They provide insights into the most important future trends and challenges, which is essential for well-informed policy-making. The number of foresight studies in the field of Public Health was limited but the number of studies is growing rapidly over last years. With these studies becoming available, their findings might become a more a regular component of population health monitoring activities. Given the relatively early stage of development of foresight studies in the field of Public health, a proper understanding and interpretation of the future studies might need some further guidance. How to deal with an (uncertain) future in the policy making process is one of the issues that needs to be addressed. This workshop starts with an interactive session to get a better understanding of the level of knowledge and needs regarding foresight studies, followed by the presentations of four different applications of foresight studies. The first one is at the global level from the institute for health metrics and evaluation (IHME) who has a long track record regarding public health data gathering and applying these, for example, to calculate the Global Burden of Disease. Next, EURO-HEALTHY project will present the Scenarios for population health inequalities in 2030 in Europe, partly based on a Web-Delphi process with a multidisciplinary panel. The third presentation will be from Public Health Wales on Futures for Wales which puts future health in the broader perspective of wellbeing. The last presentation will also be a national one, the Public Health foresight study, which has been conducted for more than 2025 years with an update published in 2020. After these presentations, ample time will be reserved for discussion on how these studies could best contribute to better public health policy making. Workshop participants will be informed about the main results of recent foresight studies, allowing them to reflect on these from their own perspective. They will get insight into the approaches and methods used in these recent studies, which may be helpful or inspiring for their own practice. Key messages Public health foresight studies are done more frequently and their findings can influence public health policy making. In this workshop, the methodology and findings of foresight studies at the global, European, and national level will be discussed.

Author(s):  
Marios Prasinos ◽  
Ioannis Basdekis ◽  
Marco Anisetti ◽  
George Spanoudakis ◽  
Dimitris D.G Koutsouris ◽  
...  

2020 ◽  
Vol 23 (4) ◽  
pp. 802-812
Author(s):  
Catherine A. Sharp ◽  
Mark A. Bellis ◽  
Karen Hughes ◽  
Kat Ford ◽  
Lisa C. G. Di Lemma

Author(s):  
Ioannis Basdekis ◽  
Konstantin Pozdniakov ◽  
Marios Prasinos ◽  
Konstantina Koloutsou

2013 ◽  
Vol 29 (2) ◽  
pp. 198-206 ◽  
Author(s):  
Paulo D. Picon ◽  
Alberto Beltrame ◽  
David Banta

Introduction: The translation of best evidence into practice has become an important purpose of policy making in health care. In Brazil, a country of continental dimensions with widespread regional and social inequalities, the dissemination and use of the best-evidence in policy making is a critical issue for the healthcare system.Objectives: The main purpose of this study is to describe an evidence-based public health policy with special emphasis on guidelines creation for high-cost medicines. We also describe how that strategy was diffused to the judiciary system and to other parts of the healthcare system.Results: We present an 11-year follow-up of a national project for creating and updating guidelines for high-cost medicines in Brazil. A total of 109 national guidelines were published (new or updated versions) for 66 selected diseases, the first such effort in Brazilian history. The project influenced the Brazilian legislature, which has recently established a Federal Law requiring national guidelines for any new technology listed for payment by the Brazilian public healthcare system.Conclusion: We were able to involve many different stakeholders in a partnership between academia and policy makers, which made possible the widespread dissemination of the clinical practice guidelines. Problems and constraints were also encountered. This evolving public health strategy might be useful for other developing countries.


2017 ◽  
Vol 20 (6) ◽  
pp. 312-320 ◽  
Author(s):  
Laura Mählmann ◽  
Matthias Reumann ◽  
Nikolaos Evangelatos ◽  
Angela Brand

Sign in / Sign up

Export Citation Format

Share Document